Professor Stephen Turner is currently a NHMRC Principal Research Fellow and Head of the Department of Microbiology, Monash University.
The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.
Dr Tyani Chan
Dr Connie Jackaman
Dr Asolina Braun
Dr Emma Grant
Professor John Fraser
December 8-9, 2021 | Online
It is with great pleasure that we invite you to be part of the 49th Annual Scientific Meeting of the Australian and New Zealand Society for Immunology, ASI 2021.
The annual meeting is a highlight of our Society’s scientific activities. This year, we will deliver a virtual event featuring our Special Interest Groups.
We will be hosting high-calibre international and national speakers that will present cutting edge research in a wide range of topics, including cancer immunology, infectious diseases, inflammation, systems immunology, autoimmunity, clinical immunology, to name just a few. With a wide spectrum from basic to clinical science, ASI 2021 will attract scientists and clinicians alike, offering an outstanding opportunity to present your latest products, technologies and services to a diverse range of experts.
The Australian and New Zealand Society for Immunology has more than 1,000 members many of whom hold membership in at least one of our 11 Special Interest Groups. We trust that ASI 2021 will attract a large group of specialist delegates.
Immunology & Cell Biology focuses on the general functioning of the immune system in its broadest sense, with a particular emphasis on its cell biology.
Areas that are covered include but are not limited to:
- Cellular immunology
- Innate and adaptive immunity
- Immune responses to pathogens
- Tumour immunology
- Immunological studies in humans and model organisms (including mouse, rat, Drosophila etc)
Clinical & Translational Immunology is an open access, fully peer-reviewed journal devoted to publishing cutting-edge advances in biomedical research for scientists and physicians. Brought to you by the editorial team of Immunology & Cell Biology, CTI covers fields including cancer biology, cardiovascular research, gene therapy, immunology, vaccine development and disease pathogenesis and therapy at the earliest phases of investigation.
Clinical & Translational Immunology seeks to cover basic, translational and clinical studies in all aspects of human immunology, including experimental models specific to human diseases.
Topics of particular interest within the journal’s scope include, but are not limited to, those listed below:
- cutting edge approaches including in vivo models of human disease that shed light on the mechanisms of immunity
- clinical studies with relevance to autoimmunity transplantation and tumor immunotherapy
- cutting edge immunoassays for monitoring clinical trials/patient responses
- infection and immunity - correlates of protection
- immunotherapies in relation to autoimmunity, primary and secondary immunodeficiencies, complement disorders and allergies
- pathogenesis and correlates of protection for autoimmune and endocrine disorders, infectious disease, malignancy and transplantation
Regional Federation: Federation of Immunological Societies of Asia-Oceania (FIMSA)
Society Website: www.immunology.org.au/
Back to Member Societies